间充质干细胞
核型
间质细胞
生物
体外
细胞
细胞疗法
细胞培养
癌症研究
细胞生物学
免疫学
遗传学
染色体
基因
作者
Brian G. Stultz,Kathleen A. McGinnis,Elaine E. Thompson,Jessica Lo Surdo,Steven R. Bauer,Deborah A. Hursh
出处
期刊:Cytotherapy
[Elsevier]
日期:2016-01-16
卷期号:18 (3): 336-343
被引量:71
标识
DOI:10.1016/j.jcyt.2015.11.017
摘要
Background aims Mesenchymal stromal cells (MSCs) are being investigated for use in cell therapy. The extensive in vitro expansion necessary to obtain sufficient cells for clinical use increases the risk that genetically abnormal cells will arise and be propagated during cell culture. Genetic abnormalities may lead to transformation and poor performance in clinical use, and are a critical safety concern for cell therapies using MSCs. Methods We used spectral karyotyping (SKY) to investigate the genetic stability of human MSCs from ten donors during passaging. Results Our data indicate that chromosomal abnormalities exist in MSCs at early passages and can be clonally propagated. The karyotypic abnormalities observed during our study diminished during passage. Conclusions Karyotyping of MSCs reveals characteristics which may be valuable in deciding the suitability of cells for further use. Karyotypic analysis is useful for monitoring the genetic stability of MSCs during expansion.
科研通智能强力驱动
Strongly Powered by AbleSci AI